Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)
OTCMKTS
· Delayed Price · Currency is USD
2.000
0.00 (0.00%)
Apr 14, 2025, 4:00 PM EDT
ZHYBF Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2016 - 2019 |
| Operating Revenue | 2.01 | 1.66 | 2.33 | 1.64 | 1.22 | Upgrade
|
| Other Revenue | 0.26 | - | - | - | - | Upgrade
|
| Revenue | 2.28 | 1.66 | 2.33 | 1.64 | 1.22 | Upgrade
|
| Revenue Growth (YoY) | 37.03% | -28.60% | 42.38% | 34.09% | 0.17% | Upgrade
|
| Cost of Revenue | 0.21 | 0.14 | 0.42 | 0.28 | 0.26 | Upgrade
|
| Gross Profit | 2.07 | 1.52 | 1.91 | 1.35 | 0.96 | Upgrade
|
| Selling, General & Admin | 1.31 | 2.6 | 1.91 | 1.16 | 0.87 | Upgrade
|
| Research & Development | 0.49 | 0.53 | 0.68 | 0.21 | 0.18 | Upgrade
|
| Operating Expenses | 1.81 | 3.12 | 2.59 | 1.37 | 1.05 | Upgrade
|
| Operating Income | 0.27 | -1.61 | -0.69 | -0.01 | -0.09 | Upgrade
|
| Interest Expense | -0.08 | -0.05 | -0.04 | -0.02 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.02 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.06 | 0.07 | 0.05 | 0.01 | 0 | Upgrade
|
| EBT Excluding Unusual Items | 0.27 | -1.59 | -0.67 | -0.03 | -0.09 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.09 | - | - | - | Upgrade
|
| Pretax Income | 0.27 | -1.68 | -0.67 | -0.03 | -0.09 | Upgrade
|
| Income Tax Expense | -0 | -0.01 | 0.01 | - | - | Upgrade
|
| Earnings From Continuing Operations | 0.27 | -1.67 | -0.68 | -0.03 | -0.09 | Upgrade
|
| Earnings From Discontinued Operations | - | -0.54 | -0.44 | - | - | Upgrade
|
| Net Income to Company | 0.27 | -2.2 | -1.13 | -0.03 | -0.09 | Upgrade
|
| Minority Interest in Earnings | 0.03 | 0.05 | - | - | - | Upgrade
|
| Net Income | 0.3 | -2.15 | -1.13 | -0.03 | -0.09 | Upgrade
|
| Net Income to Common | 0.3 | -2.15 | -1.13 | -0.03 | -0.09 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 17 | 17 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 18 | 17 | 17 | 17 | Upgrade
|
| Shares Change (YoY) | 1.85% | 2.21% | 0.81% | 2.74% | 3.33% | Upgrade
|
| EPS (Basic) | 0.02 | -0.12 | -0.07 | -0.00 | -0.01 | Upgrade
|
| EPS (Diluted) | 0.02 | -0.12 | -0.07 | -0.00 | -0.01 | Upgrade
|
| Free Cash Flow | -0.75 | -1.05 | -0.26 | 0.3 | -0.15 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.06 | -0.01 | 0.02 | -0.01 | Upgrade
|
| Gross Margin | 90.94% | 91.30% | 81.95% | 82.76% | 78.93% | Upgrade
|
| Operating Margin | 11.70% | -96.62% | -29.45% | -0.89% | -7.01% | Upgrade
|
| Profit Margin | 13.26% | -129.27% | -48.34% | -1.71% | -7.16% | Upgrade
|
| Free Cash Flow Margin | -32.74% | -63.02% | -10.96% | 18.56% | -12.64% | Upgrade
|
| EBITDA | 0.27 | -1.6 | -0.68 | -0.01 | -0.08 | Upgrade
|
| EBITDA Margin | 11.79% | -96.39% | -29.22% | -0.53% | -6.50% | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBIT | 0.27 | -1.61 | -0.69 | -0.01 | -0.09 | Upgrade
|
| EBIT Margin | 11.70% | -96.62% | -29.45% | -0.89% | -7.01% | Upgrade
|
| Revenue as Reported | 2.28 | 1.66 | 2.33 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.